Person: Karimah Es Sabar

Dr Trevor Hawkins

Dr Trevor Hawkins has been appointed to the newly created position of chief science and technology officer at MDS Inc. Hawkins joins MDS during a period of transition in the executive suite (see below). He was previously president of the molecular diagnostics business unit at GE Healthcare and senior VP development and new business initiatives…

Stephen DeFalco

Stephen DeFalco has been appointed COO of MDS Inc and will become president and CEO when he replaces retiring John Rogers at the end of 2005. Defalco is chair and CEO of US Genomics, a firm he founded in 2003. Prior to that he was president of PerkinElmer Instruments and senior VP of PerkinElmer Inc.…

Gregory McKee

Gregory McKee has been appointed president and CEO of Victoria-based Stressgen Biotechnologies Corp, replacing Dan Korpolinski. The move comes after Stressgen withdrew its preliminary prospectus for a common share offering and a decision to sell its bioreagents business to a US firm (see New Briefs). Prior to his appointment, McKee was Stressgen’s chief financial officer…